BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 16, 2003
View Archived Issues
GPI-15427 improves function of poorly preserved livers in animal model
Read More
Efficacy and safety of SU-11248 assessed in advanced solid tumors
Read More
Atlizumab in secondary osteoporosis and rheumatoid arthritis
Read More
Reepithelialization of second degree burns enhanced in pigs administered CNI-1493
Read More
BPC-157 promotes healing of bone and muscle in preclinical models
Read More
Antitumor effects described for CA4P combined with carboplatin in advanced cancer
Read More
Nonhypercalcemic vitamin D analogues newly synthesized at Schering AG
Read More
Three series of PDE4 inhibitors and their use claimed by Tanabe Seiyaku researchers
Read More
New cathepsin S inhibitors described by Aventis and AxyS (Celera Genomics)
Read More
Adenosine A2B receptor antagonists with utility in asthma, diarrhea, etc.
Read More
Merck Frosst and AxyS team claims novel cathepsin K inhibitors in recent patent
Read More
Novel anti-HIV agents prepared and tested by JT scientists
Read More
Nippon Shinyaku patent covers new TGF-beta antagonists
Read More
Heart drug may combat fungal infections
Read More
Preliminary evidence of immune response reported in Norelin trial
Read More
Positive phase II data for Neurodex in neuropathic pain
Read More
Vion terminates phase I TAPET trial
Read More
Fibrostat phase IIb trial cleared to commence
Read More
PYM-50028 completes phase I testing, advances to phase II
Read More
Concept validation study confirms potential of M-40403 as safe and active compound
Read More
Positive topline phase III results for oritavancin in bacterial skin infections
Read More
DPP IV inhibition as a strategy for controlling type 2 diabetes
Read More
PTP1B inhibitor IDD-2846 may be useful for improving insulin resistance in diabetes
Read More
Japanese group characterizes TY-51501 as potential new drug for type 2 diabetes
Read More
FR-221647, a novel ADA inhibitor with improved pharmacokinetics
Read More